Trials / Not Yet Recruiting
Not Yet RecruitingNCT07158268
A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis
A Phase 2 Multicenter, Randomized, Double-blind and Two-Stage Study to Evaluate the Efficacy and Safety of HSK47388 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 220 (estimated)
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the efficacy of multiple-dose HSK47388 versus placebo in participants with moderate-to-severe plaque psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HSK47388 | HSK47388 tablets will be administered orally, once a day |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-12-20
- Completion
- 2027-01-17
- First posted
- 2025-09-05
- Last updated
- 2025-09-05
Source: ClinicalTrials.gov record NCT07158268. Inclusion in this directory is not an endorsement.